Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-26-032146
Filing Date
2026-05-07
Accepted
2026-05-07 16:17:27
Documents
74
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q camp-20260331.htm   iXBRL 10-Q 724701
2 EX-10.1 exhibit101amendedandrestat.htm EX-10.1 19168
3 EX-31.1 a20260331ex311certification.htm EX-31.1 11410
4 EX-31.2 a20260331ex312certification.htm EX-31.2 11379
5 EX-32.1 a20260331ex321certification.htm EX-32.1 5414
6 EX-32.2 a20260331ex322certification.htm EX-32.2 5577
12 camp-20260331_g1.jpg GRAPHIC 4680
  Complete submission text file 0001628280-26-032146.txt   5288010

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT camp-20260331.xsd EX-101.SCH 49220
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT camp-20260331_cal.xml EX-101.CAL 58888
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT camp-20260331_def.xml EX-101.DEF 214618
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT camp-20260331_lab.xml EX-101.LAB 571958
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT camp-20260331_pre.xml EX-101.PRE 413939
78 EXTRACTED XBRL INSTANCE DOCUMENT camp-20260331_htm.xml XML 548827
Mailing Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139 617-651-8867
Camp4 Therapeutics Corp (Filer) CIK: 0001736730 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42365 | Film No.: 26953625
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)